RAPT Therapeutics (RAPT) Current Assets: 2020-2024
Historic Current Assets for Therapeutics (RAPT) over the last 5 years, with Sep 2024 value amounting to $102.6 million.
- Therapeutics' Current Assets fell 45.18% to $102.6 million in Q3 2024 from the same period last year, while for Sep 2024 it was $102.6 million, marking a year-over-year decrease of 45.18%. This contributed to the annual value of $161.8 million for FY2023, which is 35.98% down from last year.
- Therapeutics' Current Assets amounted to $102.6 million in Q3 2024, which was down 14.85% from $120.5 million recorded in Q2 2024.
- Therapeutics' Current Assets' 5-year high stood at $252.7 million during Q4 2022, with a 5-year trough of $102.6 million in Q3 2024.
- For the 3-year period, Therapeutics' Current Assets averaged around $181.7 million, with its median value being $187.1 million (2023).
- Per our database at Business Quant, Therapeutics' Current Assets surged by 71.20% in 2022 and then tumbled by 45.18% in 2024.
- Over the past 5 years, Therapeutics' Current Assets (Quarterly) stood at $115.6 million in 2020, then spiked by 66.93% to $193.0 million in 2021, then surged by 30.95% to $252.7 million in 2022, then plummeted by 35.98% to $161.8 million in 2023, then crashed by 45.18% to $102.6 million in 2024.
- Its last three reported values are $102.6 million in Q3 2024, $120.5 million for Q2 2024, and $148.4 million during Q1 2024.